The discovery that fat is a communicative organ with a role in everything from bone health to mood is forcing a rethink of ...

Arrowhead boasts a diversified RNAi pipeline targeting liver, lung, muscle, CNS, and obesity. Read why I recommend buying and ...

Merck rebounds on pipeline wins and a $9.2B Cidara deal, but mixed trends and Keytruda risks keep investors weighing next moves.

Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...

Company AnnouncementEPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is the first and only bispecific-based therapy approved by the FDA for ...

This is the first and only subcutaneous immune checkpoint inhibitor in Europe that a health care provider can administer in ...

Panelists discuss how shared decision-making empowers patients when choosing between IV and SC administration routes.

Panelists discuss how SC formulations enhance adherence through simpler, patient-friendly treatment delivery.

You can catch Trader Talk on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. AI’s runaway energy demand ...

Former FBI Director James Comey will make another run Wednesday at getting his criminal case dismissed, with his lawyers ...

In 2020, Darzalex Faspro (the Sub-Q version) changed the game. The infusion time went from three hours (or an hour and a half ...